帕金森病炼计划中的坚持和满意度的决定因素:16个月的适应探戈与16个月的适应探戈相比. 在监督下行走
Haneul Kim1, Forouzan Rafiei1, Meghan E Kazanski1
1Emory University.
Research square
|June 30, 2025
概括
适度的有氧运动显示出对帕金森病 (PD) 症状管理的前景. 然而,动力障碍阻碍了服从,而认知功能预测了满意度,强调了PD患者需要量身定制的运动干预措施的需要.
科学领域:
- 神经学 神经学
- 运动科学 运动科学
- 康复医学 康复医学 康复医学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特点是运动和认知缺陷.
- 适度的有氧活动被认为具有缓解这些症状的潜力.
- 了解影响坚持和满意度的患者特定因素对于有效的运动干预至关重要.
研究的目的:
- 调查帕金森病特征与遵守中度有氧活动计划之间的关联.
- 确定PD特定指标与参与者对运动干预的满意度之间的关系.
- 确定与帕金森病患者进行有氧运动时的坚持和满意度的关键预测因素.
主要方法:
- 36名患有PD的参与者参加了适应的阿根廷探戈 (TANGO) 或监督步行 (WALK) 计划16个月.
- 收集的数据包括PD特征 (运动障碍,OFF状态,步态结,疾病持续时间,Hoehn-Yahr阶段,运动和认知功能).
- 使用线性回归模型分析了PD指标与治疗遵守 (参加课程数量) 和计划满意度的关联.
主要成果:
- 参与者的整体满意度是有利的 (4.0/5.0),但项目参与度差异很大 (平均39.1次).
- 增加的运动障碍频率和持续时间与减少的计划遵守程度显著相关 (p < 0.06).
- 认知功能 (MoCA分数) 是参与者满意度的最强预测因素 (p = 0.050),其次是非运动症状 (UPDRS Part I) 和运动障碍持续时间.
结论:
- 帕金森病的运动和认知特征显著影响参与中等强度有氧运动.
- 动力障碍症是遵守的障碍,而认知功能是满意度的关键.
- 针对运动限制的量身定制的运动计划对于改善PD管理中的坚持和治疗结果至关重要.
相关概念视频
Parkinson's Disease: Treatment
389
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
389
Parkinson's Disease: Overview
718
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
718


